Zobrazeno 1 - 10
of 321
pro vyhledávání: '"Robert C, Newton"'
Autor:
Geoffrey T. Gibney, Omid Hamid, Jose Lutzky, Anthony J. Olszanski, Tara C. Mitchell, Thomas F. Gajewski, Bartosz Chmielowski, Brent A. Hanks, Yufan Zhao, Robert C. Newton, Janet Maleski, Lance Leopold, Jeffrey S. Weber
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Background Epacadostat is a potent inhibitor of the immunosuppressive indoleamine 2,3-dioxygenase 1 (IDO1) enzyme. We present phase 1 results from a phase 1/2 clinical study of epacadostat in combination with ipilimumab, an anti-cytotoxic T-
Externí odkaz:
https://doaj.org/article/5099b0af01e64192a7b84fc9a960caa6
Autor:
Timothy C. Burn, Davide Melisi, Camilla Zecchetto, Luis Féliz, Huiling Zhen, Robert C. Newton, Sherry Owens, Luc Friboulet, Antoine Hollebecque, Ian M. Silverman
Supplemental tables and figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53bf46ddbd92e6261cad46e7b7c7f670
https://doi.org/10.1158/2159-8290.22536775.v1
https://doi.org/10.1158/2159-8290.22536775.v1
Autor:
Timothy C. Burn, Davide Melisi, Camilla Zecchetto, Luis Féliz, Huiling Zhen, Robert C. Newton, Sherry Owens, Luc Friboulet, Antoine Hollebecque, Ian M. Silverman
Pemigatinib, a selective FGFR1–3 inhibitor, has demonstrated antitumor activity in FIGHT-202, a phase II study in patients with cholangiocarcinoma harboring FGFR2 fusions/rearrangements, and has gained regulatory approval in the United States. Elig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da035ad9df6005abe4dff9fbc887b35c
https://doi.org/10.1158/2159-8290.c.6548233.v1
https://doi.org/10.1158/2159-8290.c.6548233.v1
Autor:
Peggy A. Scherle, Robert C. Newton, Wenqing Yao, Jincong Zhuo, Meizhong Xu, Chunhong He, Sharon Diamond, Jason Boer, Yu Li, Richard Wynn, Elham Behshad, Jordan S. Fridman, Leslie M. Hall, Holly K. Koblish, Cindy Marando, Gengjie Yang, Qian Wang, Xiangdong Liu
PDF file - 91K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16e2ac65557a6da0e73230a1e910ea93
https://doi.org/10.1158/1078-0432.22443831.v1
https://doi.org/10.1158/1078-0432.22443831.v1
Autor:
Peggy A. Scherle, Robert C. Newton, Wenqing Yao, Jincong Zhuo, Meizhong Xu, Chunhong He, Sharon Diamond, Jason Boer, Yu Li, Richard Wynn, Elham Behshad, Jordan S. Fridman, Leslie M. Hall, Holly K. Koblish, Cindy Marando, Gengjie Yang, Qian Wang, Xiangdong Liu
PDF file - 94K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38dc9ab0796303e073ea0830c1554ad1
https://doi.org/10.1158/1078-0432.22443834
https://doi.org/10.1158/1078-0432.22443834
Autor:
Peggy A. Scherle, Robert C. Newton, Wenqing Yao, Jincong Zhuo, Meizhong Xu, Chunhong He, Sharon Diamond, Jason Boer, Yu Li, Richard Wynn, Elham Behshad, Jordan S. Fridman, Leslie M. Hall, Holly K. Koblish, Cindy Marando, Gengjie Yang, Qian Wang, Xiangdong Liu
PDF file - 66K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a72bf8abaf13e94800645d9e3c5eb8d
https://doi.org/10.1158/1078-0432.22443828
https://doi.org/10.1158/1078-0432.22443828
Autor:
Robert C. Newton
Publikováno v:
The Journal of Geology. 128:395-413
Granulite facies metamorphism of the lower crust has decreased in scale since the Late Archean, but many of its definitive features have persisted: (1) Punctuated, sometimes relatively shor...
Publikováno v:
Geochimica et Cosmochimica Acta. 279:119-142
The interaction of fluids with rock-forming minerals plays an important role in the chemical evolution of mafic and ultramafic rocks in the lower crust and upper mantle. Recent work highlights the importance of salt-rich fluids in element transport i
Autor:
Qian Wang, Sybil O'Connor, Alan Roberts, Brian W. Metcalf, Leslie Hall, Maxim Soloviev, Michael Hansbury, Greg Hollis, Xin He, Matthew C. Stubbs, Niu Shin, Wenqing Yao, Kamna Katiyar, Phillip C.C. Liu, Kathy Wang, Sharon Diamond, Brent Douty, Gengjie Yang, Dana Shuey, Maryanne B. Covington, Paul Collier, Mingming Gao, Patricia Feldman, Peggy Scherle, Timothy Burn, Andrew P. Combs, Yun-Long Li, Lynn Leffet, Robert C. Newton, Paul Waeltz, Holly Koblish, Jin Lu, Swamy Yeleswaram, Yanlong Li, Reid Huber, Robert Collins, Eddy W. Yue
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 374:211-222
The clinical use of first-generation phosphoinositide 3-kinase (PI3K)δ inhibitors in B-cell malignancies is hampered by hepatotoxicity, requiring dose reduction, treatment interruption, and/or discontinuation of therapy. In addition, potential molec
Autor:
Michael Smith, Sherry Owens, Janet Maleski, Xiaohua Gong, Lance Leopold, Robert C. Newton, Chuan Tian
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background IDO1 is the initial rate-limiting enzyme in one breakdown pathway of tryptophan. It reduces tryptophan levels and generates metabolites (e.g., kynurenine [KYN]) that contribute to tumor-associated immune suppression. Epacadostat (EPA) is a